ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0126

Should Arthrocentesis Be Attempted in the Symptomatic but Non-Effusive Knee?

Rosemina Patel1, Angie Ariza-hutchinson1, Ahsan Iqbal1, Matthew McElwee1, N. Suzanne Emil1, Sharon Nunez1, maheshwari muruganandam1, frank O'Sullivan1, Roderick Fields1, Yvonne Waters2 and Wilmer Sibbitt1, 1University of New Mexico, Albuquerque, NM, 2University of New Mexico Hospital, Corrales, NM

Meeting: ACR Convergence 2022

Keywords: Intervention

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Arthrocentesis of the painful but non-effusive knee is usually not undertaken due to a high arthrocentesis failure rate. We hypothesized that compression-assisted arthrocentesis of the symptomatic non-effusive knee would permit synovial fluid analysis and provide useful diagnostic information.

Methods: The absence of a knee effusion was determined by physical examination and ultrasound visualization. Conventional arthrocentesis first with and then without pneumatic compression was performed in 114 consecutive painful, non-effusive knees and synovial fluid was collected and analyzed for total nucleated cell (TNC) counts, TNC differential, crystals, Gram stain, and bacterial cultures.

Results: Arthrocentesis success (≥ 0.5 ml) in the symptomatic non-effusive knee was 23.7% (27/114) without compression and 57.0% (65/114) with compression. OR: 0.22 (OR: 0.23 (0.13, 0.41); p=0.0001). The volume of aspirated synovial fluid increased from 0.43±0.95 ml to 1.8±2.5; p< 0.0001) when compression was used. Fluid from the non-effusive knee demonstrated: I) Normal fluid (TNC< 200) in 41.5% (27/65) (mean TNC 56.3±37.8), II) Non-inflammatory fluid (TNC 200-2000) in 41.5% (27/65) (mean TNC 556±3304), III) Inflammatory (TNC >2000) in 6.2% (4/65) (mean TNC 30,108±26,102); and V) Crystal-induced in 10.8% (7/65) (mean TNC 7115±1625). Amongst the crystal-induced fluid, two had sodium urate crystals both with normal or non-inflammatory fluid and five had calcium pyrophosphate dihydrate (CPPD) only one of which was inflammatory.

Conclusion: Compression-assisted arthrocentesis of the symptomatic non-effusive knee is successful in most cases and detects non-effusive inter-critical gout, other crystal-induced diseases, and inflammatory arthritis. Diagnostic arthrocentesis of the symptomatic non-effusive knee should be particularly considered in cases where there has been no prior synovial fluid analysis.

Supporting image 1

Characteristics of synovial fluid in painful non-effusive joint

Supporting image 2

Volume of arthrocentesis in non-effusive knees with and without pneumatic compression

Supporting image 3

Ultrasound Image of Non-Effusive Knee with and without Pneumatic Compression (medial knee). The figure on the left is the flexed non-effusive knee, where the needle cannot access the synovial fluid because the fat pad (Fat Pad) forces fluid from the surface of the cartilage to the superior knee. The figure on the right is a non-effusive knee with the pneumatic compression that compresses the suprapatellar bursa and induces collapse driving the occult synovial fluid (Occult Extractable Fluid) inferiorly where the fluid collects over the cartilage surfaces (Cartilage) of the medial femoral condyle (Medial Femoral Condyle) displacing the fat pad (Fat Pad). The needle can then access the synovial fluid (Occult Extractable Fluid).


Disclosures: R. Patel, None; A. Ariza-hutchinson, None; A. Iqbal, None; M. McElwee, None; N. Emil, None; S. Nunez, None; m. muruganandam, None; f. O'Sullivan, None; R. Fields, None; Y. Waters, None; W. Sibbitt, None.

To cite this abstract in AMA style:

Patel R, Ariza-hutchinson A, Iqbal A, McElwee M, Emil N, Nunez S, muruganandam m, O'Sullivan f, Fields R, Waters Y, Sibbitt W. Should Arthrocentesis Be Attempted in the Symptomatic but Non-Effusive Knee? [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/should-arthrocentesis-be-attempted-in-the-symptomatic-but-non-effusive-knee/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/should-arthrocentesis-be-attempted-in-the-symptomatic-but-non-effusive-knee/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology